| Emerging role of natural products in cancer immunotherapy S Dong, X Guo, F Han, Z He, Y Wang Acta Pharmaceutica Sinica B 12 (3), 1163-1185, 2022 | 111 | 2022 |
| Plasma pharmacokinetic determination of canagliflozin and its metabolites in a type 2 diabetic rat model by UPLC-MS/MS S Dong, H Niu, Y Wu, J Jiang, Y Li, K Jiang, X Wang, M Zhang, M Han, ... Molecules 23 (5), 1229, 2018 | 19 | 2018 |
| Upregulation of UDP-glucuronosyltransferases 1a1 and 1a7 are involved in altered puerarin pharmacokinetics in type II diabetic rats S Dong, M Zhang, H Niu, K Jiang, J Jiang, Y Ma, X Wang, S Meng Molecules 23 (6), 1487, 2018 | 15 | 2018 |
| Alteration of UDP-glucuronosyltransferase 1a1, 1a7 and P-glycoprotein expression in hepatic fibrosis rats and the impact on pharmacokinetics of puerarin M Zhang, Y Liu, K Jiang, H Niu, J Jiang, S Dong, X Wang, D Wang, ... Phytomedicine 52, 264-271, 2019 | 12 | 2019 |
| An accurate and effective method for measuring osimertinib by UPLC-TOF-MS and its pharmacokinetic study in rats ST Dong, Y Li, HT Yang, Y Wu, YJ Li, CY Ding, L Meng, ZJ Dong, Y Zhang Molecules 23 (11), 2894, 2018 | 11 | 2018 |
| Bioinspired nanocomplexes comprising phenolic acid derivative and human serum albumin for cancer therapy Z Wang, Y Liu, S Li, F Meng, J Yu, S Zhou, S Dong, J Ye, L Li, C Zhang, ... Nano Letters 22 (24), 10040-10048, 2022 | 7 | 2022 |
| Glutathione Pulse Therapy: Promote Spatiotemporal Delivery of Reduction‐Sensitive Nanoparticles at the “Cellular Level” and Synergize PD‐1 Blockade Therapy S Dong, Y Zhang, X Guo, C Zhang, Z Wang, J Yu, Y Liu, C Li, Y Hu, B Sun, ... Advanced Science 9 (27), 2202744, 2022 | 5 | 2022 |
| Tumor‐Tailored Ionizable Lipid Nanoparticles Facilitate IL‐12 Circular RNA Delivery for Enhanced Lung Cancer Immunotherapy S Xu, Y Xu, NC Solek, J Chen, F Gong, AJ Varley, A Golubovic, A Pan, ... Advanced Materials, 2400307, 2024 | 2 | 2024 |
| Effects of endoplasmic reticulum stress on resveratrol metabolism. J Jiang, K Jiang, H Niu, S Dong, S Wang, S Meng | | 2019 |
